UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis

Annals of the rheumatic diseases, 2017-06, Vol.76 (6), p.1101-1136

2017

Volltextzugriff (PDF)

Lung cancer in rheumatoid arthritis. Is there a need for better risk assessment and screening?

Clinical rheumatology, 2020-03, Vol.39 (3), p.957-961

2020

Volltextzugriff (PDF)

Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis

Annals of the rheumatic diseases, 2017-06, Vol.76 (6), p.1113-1136

2017

Volltextzugriff (PDF)

Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis

Annals of the rheumatic diseases, 2017-06, Vol.76 (6), p.1102-1107

2017

Volltextzugriff (PDF)

Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial

The Lancet (British edition), 2012, Vol.379 (9827), p.1712-1720

2012

Volltextzugriff (PDF)

Factors associated with non-adherence to medications in systemic lupus erythematosus: Results from a Swedish survey

Lupus, 2024-05, Vol.33 (6), p.615-628

2024

Volltextzugriff (PDF)

Treatment of rheumatic immune-related adverse events due to cancer immunotherapy with immune checkpoint inhibitors—is it time for a paradigm shift?

Clinical rheumatology, 2021-05, Vol.40 (5), p.1687-1695

2021

Volltextzugriff (PDF)

Effectiveness of TNF inhibitor switch in RA: results from the national Swedish register

Annals of the rheumatic diseases, 2015-05, Vol.74 (5), p.890-896

2015

Volltextzugriff (PDF)

Higher depression rates and similar cardiovascular comorbidity in psoriatic arthritis compared with rheumatoid arthritis and diabetes mellitus

Therapeutic advances in musculoskeletal disease, 2020, Vol.12, p.1759720X20976975-1759720X20976975

2020

Volltextzugriff (PDF)

Risk of lung cancer in rheumatoid arthritis and in relation to autoantibody positivity and smoking

Rheumatic & musculoskeletal diseases open, 2022-10, Vol.8 (2), p.e002465

2022

Volltextzugriff (PDF)

Could severe COVID-19 be considered a complementopathy?

Lupus science & medicine, 2020-05, Vol.7 (1), p.e000415

2020

Volltextzugriff (PDF)

Comparison of immune checkpoint inhibitor-induced arthritis and reactive arthritis to inform therapeutic strategy

Biomedicine & pharmacotherapy, 2022-04, Vol.148, p.112687-112687, Article 112687

2022

Volltextzugriff (PDF)

Editorial: Advance in B-cell therapies for the treatment of rheumatic and musculoskeletal diseases

Frontiers in medicine, 2022-09, Vol.9, p.1020859

2022

Volltextzugriff (PDF)

Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

Arthritis research & therapy, 2016-02, Vol.18 (50), p.50-50, Article 50

2016

Volltextzugriff (PDF)

The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs: a Swedish nationwide study (COVID-19-REUMA)

Microbiology spectrum, 2024, Vol.12 (4), p.e0298123-e0298123

2024

Volltextzugriff (PDF)

Protective Effect of the HIF-1A Pro582Ser Polymorphism on Severe Diabetic Retinopathy

Journal of Diabetes Research, 2019-01, Vol.2019 (2019), p.1-8

2019

Volltextzugriff (PDF)

Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden

Rheumatic & musculoskeletal diseases open, 2023-12, Vol.9 (4), p.e003648

2023

Volltextzugriff (PDF)

Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study

Rheumatic & musculoskeletal diseases open, 2023-03, Vol.9 (1), p.e002898

2023

Volltextzugriff (PDF)

Autoimmunity: Pathogenesis, Clinical Aspects and Therapy of Specific Autoimmune Diseases

Katerina Chatzidionysiou

2015

Volltextzugriff (PDF)

Tocilizumab decreases T cells but not macrophages in the synovium of patients with rheumatoid arthritis while it increases the levels of serum interleukin-6 and RANKL

Rheumatic & musculoskeletal diseases open, 2021-06, Vol.7 (2), p.e001662

2021

Volltextzugriff (PDF)

Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision

Rheumatic & musculoskeletal diseases open, 2021-12, Vol.7 (3), p.e001987

2021

Volltextzugriff (PDF)

Association between number and type of different ACPA fine specificities with lung abnormalities in early, untreated rheumatoid arthritis

Rheumatic & musculoskeletal diseases open, 2020-09, Vol.6 (2), p.e001278-10

2020

Volltextzugriff (PDF)

Corrigendum to “Protective Effect of the HIF-1A Pro582Ser Polymorphism on Severe Diabetic Retinopathy”

Journal of Diabetes Research, 2021, Vol.2021, p.9827150-1

2021

Volltextzugriff (PDF)

How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers

Rheumatic & musculoskeletal diseases open, 2020-09, Vol.6 (2), p.e001363

2020

Volltextzugriff (PDF)

1 – 25 von 90

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(63)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Medicin Och Hälsovetenskap
(72)
Science & Technology
(63)
Life Sciences & Biomedicine
(62)
Rheumatology
(58)
Humans
(44)
Rheumatoid Arthritis
(42)
Arthritis, Rheumatoid - Drug Therapy
(25)
Patients
(24)
Clinical Medicine
(20)
Antirheumatic Agents - Therapeutic Use
(19)
Arthritis
(17)
Female
(17)
Male
(17)
Reumatologi Och Inflammation
(16)
Clinical Trials
(15)
Middle Aged
(15)
Rheumatology And Autoimmunity
(14)
Treatment Outcome
(14)
Adult
(13)
Klinisk Medicin
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis

Lung cancer in rheumatoid arthritis. Is there a need for better risk assessment and screening?

Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis

Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis

Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial

Factors associated with non-adherence to medications in systemic lupus erythematosus: Results from a Swedish survey

Treatment of rheumatic immune-related adverse events due to cancer immunotherapy with immune checkpoint inhibitors—is it time for a paradigm shift?

Effectiveness of TNF inhibitor switch in RA: results from the national Swedish register

Higher depression rates and similar cardiovascular comorbidity in psoriatic arthritis compared with rheumatoid arthritis and diabetes mellitus

Risk of lung cancer in rheumatoid arthritis and in relation to autoantibody positivity and smoking

Anakinra or tocilizumab in patients admitted to hospital with severe covid-19 at high risk of deterioration (IMMCoVA): A randomized, controlled, open-label trial

Could severe COVID-19 be considered a complementopathy?

Comparison of immune checkpoint inhibitor-induced arthritis and reactive arthritis to inform therapeutic strategy

Editorial: Advance in B-cell therapies for the treatment of rheumatic and musculoskeletal diseases

Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs: a Swedish nationwide study (COVID-19-REUMA)

Protective Effect of the HIF-1A Pro582Ser Polymorphism on Severe Diabetic Retinopathy

Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden

Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study

Autoimmunity: Pathogenesis, Clinical Aspects and Therapy of Specific Autoimmune Diseases

Tocilizumab decreases T cells but not macrophages in the synovium of patients with rheumatoid arthritis while it increases the levels of serum interleukin-6 and RANKL

Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision

Association between number and type of different ACPA fine specificities with lung abnormalities in early, untreated rheumatoid arthritis

Corrigendum to “Protective Effect of the HIF-1A Pro582Ser Polymorphism on Severe Diabetic Retinopathy”

How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers

Suchergebnisse filtern